Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?-Reference-Cited by-同舟云学术

Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?

Published:2018-03-12 Issue:5 Volume:117 Page:840-844
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Martins Mário R.¹^ORCID,Santos Rogério L. d.¹,Jatahy Kleber d. N.²,Matta Marina C. d.²,Batista Thales P.³,Júnior José Iran C.¹²,Begnami Maria D. F. S.⁴,Torres Leuridan C.¹²

Affiliation:

1. Oncology Surgical Department; Sociedade Pernambucana de Combate ao Câncer-Hospital do Cancer de Pernambuco (SPCC-HCP); Recife Brazil

2. Translational Research Laboratory Prof. C. A. Hart; Instituto de Medicina Integral Prof. Fernando Figueira (IMIP); Recife Brazil

3. Surgical Department; Instituto de Medicina Integral Prof. Fernando Figueira (IMIP); Recife Brazil

4. Anatomic Pathology Department; A.C. Camargo Cancer Center; São Paulo Brazil

Funder

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.25001/fullpdf

Reference28 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer;Hsu;BMC Palliat Care,2017

3. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer;Lee;Br J Cancer,2008

4. T cell defined tumor antigens;Van den Eynde;Curr Opin Immunol,1997

5. CD28-mediated co-stimulation: a quantitative support for TCR signalling;Acuto;Nat Rev Immunol,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint expression as prognostic biomarker candidates in non‐small cell lung carcinoma patients;Journal of Surgical Oncology;2024-07-07

2. Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma;Journal of Surgical Oncology;2024-06-10

3. Construction of an immune-related risk score signature for gastric cancer based on multi-omics data;Scientific Reports;2024-01-16

4. Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy;Biomarker Research;2022-08-30

5. High soluble OX40 levels correlate with metastatic gastric cancer;Journal of Surgical Oncology;2022-06-11